Published: 2018-12-08

Articles

BUILDING A STRUCTURED MONITORING AND EVALUATING SYSTEM OF POSTMARKETING DRUG USE IN SHANGHAI

Wenmin Du, Mitchell Levine, Longxing Wang, Chengdong Yi, Hongmin Wang, Xiaoyu Wang, Hongjuan Xie Xie, Jianglong Xu, Huilin Jin, Tongchun Wang, Gang Huang, Ye Wu
Abstract 242 | PDF Downloads 152

COUNSELING REGARDING PREGNANCY- RELATED DRUG EXPOSURES BY FAMILY PHYSICIANS IN ONTARIO

Jodi Goodwin, Scott Rieder, Michael J Rieder, Doreen Matsui
Abstract 177 | PDF Downloads 99

45 YEARS LATER… WHERE DO WE STAND?

Mercédes Benegbi
Abstract 161 | PDF Downloads 87

PAEDIATRIC ADVERSE DRUG REACTION REPORTING: UNDERSTANDING AND FUTURE DIRECTIONS

Bruce C Carleton, M Anne Smith, Michaela N Gelin, Susan C Heathcote
Abstract 470 | PDF Downloads 231

DRUGS IN PREGNANCY: ACKNOWLEDGING CHALLENGES - FINDING SOLUTIONS

Gideon Koren, Stuart MacLeod, Donald Davis
Abstract 798 | PDF Downloads 128

DRUGS USED IN PREGNANCY: THE REGULATORY PROCESS

Anne Tomalin
Abstract 191 | PDF Downloads 319

THE WAY WOMEN PERCEIVE TERATOGENIC RISK

Gideon Koren
Abstract 851 | PDF Downloads 294

INACTIVE PHARMACEUTICAL INGREDIENTS: IMPLICATIONS FOR PREGNANCY

Yaron Finkelstein, Massoud Rezvani, Facundo Garcia-Bournissen, Laila Nurmohamed, Gideon Koren
Abstract 1477 | PDF Downloads 699

CHALLENGES IN DRUG USE NEAR TERM AND DURING DELIVERY

Dan Farine
Abstract 153 | PDF Downloads 99

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 134 | PDF Downloads 85

COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY

Myla Moretti
Abstract 155 | PDF Downloads 75

CRITICAL APPRAISAL ROUNDS: A NEW TRAINING MODEL FOR CLINICAL PHARMACOLOGISTS

Gideon Koren, Irena Nulman
Abstract 803 | PDF Downloads 107

USE OF CELECOXIB IMMEDIATELY POST MARKETING IN CANADA: ACUTE OR CHRONIC PAI N?

Anita L Kozyrskyj, Colette Raymond, Amber Racher Racher
Abstract 198 | PDF Downloads 130